Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Esmee P Hoefsmit"'
Autor:
Annegien Broeks, Sofie Wilgenhof, John B A G Haanen, Karolina Sikorska, Christian U Blank, Judith M Versluis, Jan Willem B de Groot, Esmee P Hoefsmit, Elisa A Rozeman, Petros Dimitriadis, Aysegul Sari, Daan van den Broek, Disha Rao, Ruben Lacroix, Lindsay G Grijpink-Ongering, Marta Lopez-Yurda, Birthe C Heeres, Bart A van de Wiel, Claudie Flohil, Stijn W T P J Heijmink, Marieke A Vollebergh, Johannes V van Thienen
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss 7 (2023)
Background Continuous combination of MAPK pathway inhibition (MAPKi) and anti-programmed death-(ligand) 1 (PD-(L)1) showed high response rates, but only limited improvement in progression-free survival (PFS) at the cost of a high frequency of treatme
Externí odkaz:
https://doaj.org/article/85f4bb454d4548b7b0eddc4aff9da5e2
Autor:
Stefani Spranger, Fiona Chatterjee, Esmee P Hoefsmit, Tim B Fessenden, Lauren E Stopfer, Julian Zulueta, Josh Mesfin, Therese Cordero Dumit, Irene Reijers, Christian Blank, Forest White
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 7 (2022)
Background For effective tumor elimination, cytotoxic CD8+ T cells must recognize tumor-derived antigens presented on class I major histocompatibility complex (MHC-I). Despite a general association between the expression of immunogenic antigens, typi
Externí odkaz:
https://doaj.org/article/6e47349a08334a24aaee85b7133f5532
Autor:
Annegien Broeks, Ines Pires da Silva, Sarah Warren, Pia Kvistborg, Georgina V Long, Richard A Scolyer, Christian U Blank, Esmee P Hoefsmit, Elisa A Rozeman, Trieu My Van, Petros Dimitriadis, Jordan W Conway, Jacqueline E van der Wal, Steven L C Ketelaars, Kaspar Bresser, Ron M Kerkhoven, Jason W Reeves, Ellen W Kapiteijn, Ton N M Schumacher
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
Background The profound disparity in response to immune checkpoint blockade (ICB) by cutaneous melanoma (CM) and uveal melanoma (UM) patients is not well understood. Therefore, we characterized metastases of CM and UM from the same metastatic site (l
Externí odkaz:
https://doaj.org/article/57566697358f40ef905dd40c8195aef6
Autor:
Christian U. Blank, Maarten Altelaar, Reinhard Dummer, Dirk Schadendorf, Georgina V. Long, Alexander C.J. van Akkooi, Liesbeth Hoekman, Judith M. Versluis, Irene L.M. Reijers, Elisa A. Rozeman, Franziska Völlmy, Esmee P. Hoefsmit
Figure S5 shows that complement factor B (CFB), component 7 (C7) and alpha-1B-glycoportein (A1BG) expression are increased upon melanoma progression and recurrence.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0eff2f8a8ef3578e8d03ed12f2d2bff3
https://doi.org/10.1158/2767-9764.22546879.v1
https://doi.org/10.1158/2767-9764.22546879.v1
Autor:
Christian U. Blank, Maarten Altelaar, Reinhard Dummer, Dirk Schadendorf, Georgina V. Long, Alexander C. J. van Akkooi, Liesbeth Hoekman, Judith M. Versluis, Irene L. M. Reijers, Elisa A. Rozeman, Franziska Völlmy, Esmee P. Hoefsmit
Table S2 shows the patient characteristics OpACIN-neo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d3d766be71944993e367996d02533fa
https://doi.org/10.1158/2767-9764.22546870.v1
https://doi.org/10.1158/2767-9764.22546870.v1
Autor:
Tim B Fessenden, Lauren E Stopfer, Fiona Chatterjee, Julian Zulueta, Josh Mesfin, Therese Cordero Dumit, Irene Reijers, Esmee P Hoefsmit, Christian Blank, Forest White, Stefani Spranger
Publikováno v:
Journal for ImmunoTherapy of Cancer. 10:e004159
BackgroundFor effective tumor elimination, cytotoxic CD8+ T cells must recognize tumor-derived antigens presented on class I major histocompatibility complex (MHC-I). Despite a general association between the expression of immunogenic antigens, typic